Medicenna Therapeutics Ownership 2024 | Who Owns Medicenna Therapeutics Now?
Institutional Ownership
0.19%
Insider Ownership
23.65%
Retail Ownership
76.16%
Institutional Holders
3.00
Medicenna Therapeutics Institutional Shareholders
Institutional Shareholders by % of Total Shares
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| WELLS FARGO & COMPANY/MN | - | - | - | -715 | -100.00% | - | Dec 31, 2023 |
| TOCQUEVILLE ASSET MANAGEMENT L.P. | - | - | - | -79,000 | -100.00% | - | Dec 31, 2023 |
| MORGAN STANLEY | - | - | - | -1,800 | -100.00% | - | Dec 31, 2023 |
| TORONTO DOMINION BANK | - | - | - | -1,677 | -100.00% | - | Dec 31, 2023 |
| ROYAL BANK OF CANADA | - | - | - | -173,945 | -100.00% | - | Dec 31, 2023 |
| RENAISSANCE TECHNOLOGIES LLC | - | - | - | -85,113 | -100.00% | - | Dec 31, 2023 |
| GEODE CAPITAL MANAGEMENT, LLC | - | - | - | -34,144 | -100.00% | - | Dec 31, 2023 |
| MILLENNIUM MANAGEMENT LLC | - | - | - | -24,988 | -100.00% | - | Dec 31, 2023 |
| LETKO, BROSSEAU & ASSOCIATES INC | - | - | - | -120,000 | -100.00% | - | Dec 31, 2023 |
| HUDSON BAY CAPITAL MANAGEMENT LP | - | - | - | -780,564 | -100.00% | - | Dec 31, 2023 |
| CITADEL ADVISORS LLC | - | - | - | -27,626 | -100.00% | - | Dec 31, 2023 |
| SIGMA PLANNING CORP | - | - | - | -634,550 | -100.00% | - | Dec 31, 2023 |
| TWO SIGMA SECURITIES, LLC | - | - | - | -38,092 | -100.00% | - | Dec 31, 2023 |
| VERITION FUND MANAGEMENT LLC | - | - | - | -555,392 | -100.00% | - | Dec 31, 2023 |
| MCKINLEY CARTER WEALTH SERVICES, INC. | - | - | - | -79,259 | -100.00% | - | Dec 31, 2023 |
| WARBERG ASSET MANAGEMENT LLC | - | - | - | -20,000 | -100.00% | - | Dec 31, 2023 |
| ADVISOR GROUP HOLDINGS, INC. | - | - | - | -22,000 | -100.00% | - | Dec 31, 2023 |
| PATRIOT FINANCIAL GROUP INSURANCE AGENCY, LLC | - | - | - | -15,000 | -100.00% | - | Dec 31, 2023 |
| WORTH VENTURE PARTNERS, LLC | - | - | - | -1,088,938 | -100.00% | - | Dec 31, 2023 |
| GREAT VALLEY ADVISOR GROUP, INC. | - | - | - | -19,500 | -100.00% | - | Dec 31, 2023 |
Medicenna Therapeutics's largest institutional shareholder is WELLS FARGO & COMPANY/MN, holding 0.00% of the company's total share outstanding, currently valued at -. The top 10 institutional shareholders own together 0.00% of the company.
Institutional Shareholders by % of Total Assets
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| WELLS FARGO & COMPANY/MN | - | - | - | -715 | -100.00% | - | Dec 31, 2023 |
| TOCQUEVILLE ASSET MANAGEMENT L.P. | - | - | - | -79,000 | -100.00% | - | Dec 31, 2023 |
| MORGAN STANLEY | - | - | - | -1,800 | -100.00% | - | Dec 31, 2023 |
| TORONTO DOMINION BANK | - | - | - | -1,677 | -100.00% | - | Dec 31, 2023 |
| ROYAL BANK OF CANADA | - | - | - | -173,945 | -100.00% | - | Dec 31, 2023 |
| RENAISSANCE TECHNOLOGIES LLC | - | - | - | -85,113 | -100.00% | - | Dec 31, 2023 |
| GEODE CAPITAL MANAGEMENT, LLC | - | - | - | -34,144 | -100.00% | - | Dec 31, 2023 |
| MILLENNIUM MANAGEMENT LLC | - | - | - | -24,988 | -100.00% | - | Dec 31, 2023 |
| LETKO, BROSSEAU & ASSOCIATES INC | - | - | - | -120,000 | -100.00% | - | Dec 31, 2023 |
| HUDSON BAY CAPITAL MANAGEMENT LP | - | - | - | -780,564 | -100.00% | - | Dec 31, 2023 |
| CITADEL ADVISORS LLC | - | - | - | -27,626 | -100.00% | - | Dec 31, 2023 |
| SIGMA PLANNING CORP | - | - | - | -634,550 | -100.00% | - | Dec 31, 2023 |
| TWO SIGMA SECURITIES, LLC | - | - | - | -38,092 | -100.00% | - | Dec 31, 2023 |
| VERITION FUND MANAGEMENT LLC | - | - | - | -555,392 | -100.00% | - | Dec 31, 2023 |
| MCKINLEY CARTER WEALTH SERVICES, INC. | - | - | - | -79,259 | -100.00% | - | Dec 31, 2023 |
| WARBERG ASSET MANAGEMENT LLC | - | - | - | -20,000 | -100.00% | - | Dec 31, 2023 |
| ADVISOR GROUP HOLDINGS, INC. | - | - | - | -22,000 | -100.00% | - | Dec 31, 2023 |
| PATRIOT FINANCIAL GROUP INSURANCE AGENCY, LLC | - | - | - | -15,000 | -100.00% | - | Dec 31, 2023 |
| WORTH VENTURE PARTNERS, LLC | - | - | - | -1,088,938 | -100.00% | - | Dec 31, 2023 |
| GREAT VALLEY ADVISOR GROUP, INC. | - | - | - | -19,500 | -100.00% | - | Dec 31, 2023 |
The largest Medicenna Therapeutics shareholder by % of total assets is WELLS FARGO & COMPANY/MN. The company owns 0.00 shares of Medicenna Therapeutics (MDNA), representing 0.00% of its total assets.
Institutional Buyers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| WELLS FARGO & COMPANY/MN | - | - | - | -715 | -100.00% | - | Dec 31, 2023 |
| TORONTO DOMINION BANK | - | - | - | -1,677 | -100.00% | - | Dec 31, 2023 |
| MORGAN STANLEY | - | - | - | -1,800 | -100.00% | - | Dec 31, 2023 |
| PATRIOT FINANCIAL GROUP INSURANCE AGENCY, LLC | - | - | - | -15,000 | -100.00% | - | Dec 31, 2023 |
| GREAT VALLEY ADVISOR GROUP, INC. | - | - | - | -19,500 | -100.00% | - | Dec 31, 2023 |
| WARBERG ASSET MANAGEMENT LLC | - | - | - | -20,000 | -100.00% | - | Dec 31, 2023 |
| ADVISOR GROUP HOLDINGS, INC. | - | - | - | -22,000 | -100.00% | - | Dec 31, 2023 |
| MILLENNIUM MANAGEMENT LLC | - | - | - | -24,988 | -100.00% | - | Dec 31, 2023 |
| CITADEL ADVISORS LLC | - | - | - | -27,626 | -100.00% | - | Dec 31, 2023 |
| GEODE CAPITAL MANAGEMENT, LLC | - | - | - | -34,144 | -100.00% | - | Dec 31, 2023 |
| TWO SIGMA SECURITIES, LLC | - | - | - | -38,092 | -100.00% | - | Dec 31, 2023 |
| TOCQUEVILLE ASSET MANAGEMENT L.P. | - | - | - | -79,000 | -100.00% | - | Dec 31, 2023 |
| MCKINLEY CARTER WEALTH SERVICES, INC. | - | - | - | -79,259 | -100.00% | - | Dec 31, 2023 |
| RENAISSANCE TECHNOLOGIES LLC | - | - | - | -85,113 | -100.00% | - | Dec 31, 2023 |
| LETKO, BROSSEAU & ASSOCIATES INC | - | - | - | -120,000 | -100.00% | - | Dec 31, 2023 |
| ROYAL BANK OF CANADA | - | - | - | -173,945 | -100.00% | - | Dec 31, 2023 |
| VERITION FUND MANAGEMENT LLC | - | - | - | -555,392 | -100.00% | - | Dec 31, 2023 |
| SIGMA PLANNING CORP | - | - | - | -634,550 | -100.00% | - | Dec 31, 2023 |
| HUDSON BAY CAPITAL MANAGEMENT LP | - | - | - | -780,564 | -100.00% | - | Dec 31, 2023 |
| WORTH VENTURE PARTNERS, LLC | - | - | - | -1,088,938 | -100.00% | - | Dec 31, 2023 |
As of Dec 31 2023, Medicenna Therapeutics's largest institutional buyer is WELLS FARGO & COMPANY/MN. The company purchased -0.71K stocks of MDNA, valued at -.
Institutional Sellers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| AIGH CAPITAL MANAGEMENT LLC | - | - | - | -4,339,983 | -100.00% | - | Dec 31, 2023 |
| WORTH VENTURE PARTNERS, LLC | - | - | - | -1,088,938 | -100.00% | - | Dec 31, 2023 |
| HUDSON BAY CAPITAL MANAGEMENT LP | - | - | - | -780,564 | -100.00% | - | Dec 31, 2023 |
| SIGMA PLANNING CORP | - | - | - | -634,550 | -100.00% | - | Dec 31, 2023 |
| VERITION FUND MANAGEMENT LLC | - | - | - | -555,392 | -100.00% | - | Dec 31, 2023 |
| ROYAL BANK OF CANADA | - | - | - | -173,945 | -100.00% | - | Dec 31, 2023 |
| LETKO, BROSSEAU & ASSOCIATES INC | - | - | - | -120,000 | -100.00% | - | Dec 31, 2023 |
| RENAISSANCE TECHNOLOGIES LLC | - | - | - | -85,113 | -100.00% | - | Dec 31, 2023 |
| MCKINLEY CARTER WEALTH SERVICES, INC. | - | - | - | -79,259 | -100.00% | - | Dec 31, 2023 |
| TOCQUEVILLE ASSET MANAGEMENT L.P. | - | - | - | -79,000 | -100.00% | - | Dec 31, 2023 |
| TWO SIGMA SECURITIES, LLC | - | - | - | -38,092 | -100.00% | - | Dec 31, 2023 |
| GEODE CAPITAL MANAGEMENT, LLC | - | - | - | -34,144 | -100.00% | - | Dec 31, 2023 |
| CITADEL ADVISORS LLC | - | - | - | -27,626 | -100.00% | - | Dec 31, 2023 |
| MILLENNIUM MANAGEMENT LLC | - | - | - | -24,988 | -100.00% | - | Dec 31, 2023 |
| ADVISOR GROUP HOLDINGS, INC. | - | - | - | -22,000 | -100.00% | - | Dec 31, 2023 |
| WARBERG ASSET MANAGEMENT LLC | - | - | - | -20,000 | -100.00% | - | Dec 31, 2023 |
| GREAT VALLEY ADVISOR GROUP, INC. | - | - | - | -19,500 | -100.00% | - | Dec 31, 2023 |
| PATRIOT FINANCIAL GROUP INSURANCE AGENCY, LLC | - | - | - | -15,000 | -100.00% | - | Dec 31, 2023 |
| MORGAN STANLEY | - | - | - | -1,800 | -100.00% | - | Dec 31, 2023 |
| TORONTO DOMINION BANK | - | - | - | -1,677 | -100.00% | - | Dec 31, 2023 |
As of Dec 31 2023, Medicenna Therapeutics's biggest institutional seller is AIGH CAPITAL MANAGEMENT LLC. The company sold -4.34M shares of MDNA, valued at -.
Institutional New positions
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|
Institutional Sold Out
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| AIGH CAPITAL MANAGEMENT LLC | - | - | - | -4,339,983 | -100.00% | - | Dec 31, 2023 |
| WORTH VENTURE PARTNERS, LLC | - | - | - | -1,088,938 | -100.00% | - | Dec 31, 2023 |
| HUDSON BAY CAPITAL MANAGEMENT LP | - | - | - | -780,564 | -100.00% | - | Dec 31, 2023 |
| SIGMA PLANNING CORP | - | - | - | -634,550 | -100.00% | - | Dec 31, 2023 |
| VERITION FUND MANAGEMENT LLC | - | - | - | -555,392 | -100.00% | - | Dec 31, 2023 |
| ROYAL BANK OF CANADA | - | - | - | -173,945 | -100.00% | - | Dec 31, 2023 |
| LETKO, BROSSEAU & ASSOCIATES INC | - | - | - | -120,000 | -100.00% | - | Dec 31, 2023 |
| RENAISSANCE TECHNOLOGIES LLC | - | - | - | -85,113 | -100.00% | - | Dec 31, 2023 |
| MCKINLEY CARTER WEALTH SERVICES, INC. | - | - | - | -79,259 | -100.00% | - | Dec 31, 2023 |
| TOCQUEVILLE ASSET MANAGEMENT L.P. | - | - | - | -79,000 | -100.00% | - | Dec 31, 2023 |
| TWO SIGMA SECURITIES, LLC | - | - | - | -38,092 | -100.00% | - | Dec 31, 2023 |
| GEODE CAPITAL MANAGEMENT, LLC | - | - | - | -34,144 | -100.00% | - | Dec 31, 2023 |
| CITADEL ADVISORS LLC | - | - | - | -27,626 | -100.00% | - | Dec 31, 2023 |
| MILLENNIUM MANAGEMENT LLC | - | - | - | -24,988 | -100.00% | - | Dec 31, 2023 |
| ADVISOR GROUP HOLDINGS, INC. | - | - | - | -22,000 | -100.00% | - | Dec 31, 2023 |
| WARBERG ASSET MANAGEMENT LLC | - | - | - | -20,000 | -100.00% | - | Dec 31, 2023 |
| GREAT VALLEY ADVISOR GROUP, INC. | - | - | - | -19,500 | -100.00% | - | Dec 31, 2023 |
| PATRIOT FINANCIAL GROUP INSURANCE AGENCY, LLC | - | - | - | -15,000 | -100.00% | - | Dec 31, 2023 |
| MORGAN STANLEY | - | - | - | -1,800 | -100.00% | - | Dec 31, 2023 |
| TORONTO DOMINION BANK | - | - | - | -1,677 | -100.00% | - | Dec 31, 2023 |
| WELLS FARGO & COMPANY/MN | - | - | - | -715 | -100.00% | - | Dec 31, 2023 |
Medicenna Therapeutics's largest sold out institutional shareholder by shares sold is AIGH CAPITAL MANAGEMENT LLC, sold -4.34M shares, valued at -, as of undefined.
Medicenna Therapeutics Mutual Fund Holders
| Name | % Total Assets | Total Shares | Change Amount | Change % | Date |
|---|---|---|---|---|---|
| FIDELITY CONCORD STREET TRUST | 0.00% | 34,144 | - | - | Feb 29, 2024 |
Medicenna Therapeutics's largest mutual fund holder by % of total assets is "FIDELITY CONCORD STREET TRUST", owning 34.14K shares, compromising 0.00% of its total assets.
Medicenna Therapeutics Institutional Ownership Trends
Institutional Holdings Trend
| Date | Holdings | Change % |
|---|---|---|
| 31 Dec, 23 | 3 | -88.00% |
| 30 Sep, 23 | 25 | -3.85% |
| 30 Jun, 23 | 26 | - |
| 31 Mar, 23 | 26 | -3.70% |
| 31 Dec, 22 | 27 | -3.57% |
| 30 Sep, 22 | 28 | 47.37% |
| 30 Jun, 22 | 19 | -5.00% |
| 31 Mar, 22 | 20 | -13.04% |
| 31 Dec, 21 | 23 | -8.00% |
| 30 Sep, 21 | 25 | - |
| 30 Jun, 21 | 25 | -13.79% |
| 31 Mar, 21 | 29 | 45.00% |
| 31 Dec, 20 | 20 | 42.86% |
| 30 Sep, 20 | 14 | 1300.00% |
| 30 Jun, 20 | 1 | - |
As of 31 Dec 23, 3 institutions are holding Medicenna Therapeutics's shares, representing a decrease of -88.00% compared to the previous quarter.
Shares Outstanding Trend
| Date | Shares Outstanding | Change % |
|---|---|---|
| 31 Dec, 23 | 128,978 | -98.44% |
| 30 Sep, 23 | 8,281,040 | -3.91% |
| 30 Jun, 23 | 8,617,865 | -1.65% |
| 31 Mar, 23 | 8,762,397 | -8.71% |
| 31 Dec, 22 | 9,598,439 | -1.94% |
| 30 Sep, 22 | 9,788,228 | 117.69% |
| 30 Jun, 22 | 4,496,499 | 4.96% |
| 31 Mar, 22 | 4,284,086 | -3.59% |
| 31 Dec, 21 | 4,443,499 | 45.89% |
| 30 Sep, 21 | 3,045,786 | -39.29% |
| 30 Jun, 21 | 5,016,683 | -9.27% |
| 31 Mar, 21 | 5,529,053 | 139.38% |
| 31 Dec, 20 | 2,309,732 | 20.97% |
| 30 Sep, 20 | 1,909,281 | 3377.74% |
| 30 Jun, 20 | 54,900 | - |
Medicenna Therapeutics (MDNA) has 128.98K shares outstanding as of 31 Dec 23, down -98.44% compared to the previous quarter.
Institutional Ownership Trend
| Date | Ownership % | Change % |
|---|---|---|
| 31 Dec, 23 | 0.19% | 0.13% |
| 30 Sep, 23 | 11.89% | 7.76% |
| 30 Jun, 23 | 12.38% | 7.80% |
| 31 Mar, 23 | 12.60% | 6.63% |
| 31 Dec, 22 | 13.78% | 5.81% |
| 30 Sep, 22 | 15.40% | 24.00% |
| 30 Jun, 22 | 8.01% | 13.47% |
| 31 Mar, 22 | 7.71% | 11.39% |
| 31 Dec, 21 | 8.23% | 25.62% |
| 30 Sep, 21 | 5.67% | 6.46% |
| 30 Jun, 21 | 9.37% | 7.56% |
| 31 Mar, 21 | 11.13% | 50.61% |
| 31 Dec, 20 | 4.69% | 30.70% |
| 30 Sep, 20 | 3.91% | 30297.71% |
| 30 Jun, 20 | 0.11% | - |
As of 31 Dec 23, Medicenna Therapeutics is held by 0.19% institutional shareholders, representing a 0.13% growth compared to 30 Sep 23.
Institutional Increased Positions Trend
| Date | Increased Positions | Change % |
|---|---|---|
| 31 Dec, 23 | 1 | -85.71% |
| 30 Sep, 23 | 7 | 16.67% |
| 30 Jun, 23 | 6 | 20.00% |
| 31 Mar, 23 | 5 | -58.33% |
| 31 Dec, 22 | 12 | -33.33% |
| 30 Sep, 22 | 18 | 157.14% |
| 30 Jun, 22 | 7 | -22.22% |
| 31 Mar, 22 | 9 | -10.00% |
| 31 Dec, 21 | 10 | -16.67% |
| 30 Sep, 21 | 12 | -25.00% |
| 30 Jun, 21 | 16 | -11.11% |
| 31 Mar, 21 | 18 | 38.46% |
| 31 Dec, 20 | 13 | -7.14% |
| 30 Sep, 20 | 14 | 1300.00% |
| 30 Jun, 20 | 1 | - |
1 institutional shareholders have increased their position in MDNA stock as of 31 Dec 23 compared to 7 in the previous quarter (a -85.71% decrease).
Institutional Reduced Positions Trend
| Date | Reduced Positions | Change % |
|---|---|---|
| 31 Dec, 23 | - | -100.00% |
| 30 Sep, 23 | 6 | -14.29% |
| 30 Jun, 23 | 7 | 16.67% |
| 31 Mar, 23 | 6 | 100.00% |
| 31 Dec, 22 | 3 | - |
| 30 Sep, 22 | 3 | - |
| 30 Jun, 22 | 3 | -25.00% |
| 31 Mar, 22 | 4 | -42.86% |
| 31 Dec, 21 | 7 | 40.00% |
| 30 Sep, 21 | 5 | 66.67% |
| 30 Jun, 21 | 3 | - |
| 31 Mar, 21 | 3 | -40.00% |
| 31 Dec, 20 | 5 | - |
| 30 Sep, 20 | - | - |
| 30 Jun, 20 | - | - |
- institutional shareholders have reduced their position in MDNA stock as of 31 Dec 23 compared to 6 in the previous quarter (a -100.00% decrease).
All Institutional Ownership Trend Data
| Date | Holdings | Change % | Shares Outstanding | Change % | Ownership % | Change % | Increased Positions | Change % | Reduced Positions | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| 31 Dec, 23 | 3 | -88.00% | 128,978 | -98.44% | 0.19% | 0.13% | 1 | -85.71% | - | -100.00% |
| 30 Sep, 23 | 25 | -3.85% | 8,281,040 | -3.91% | 11.89% | 7.76% | 7 | 16.67% | 6 | -14.29% |
| 30 Jun, 23 | 26 | - | 8,617,865 | -1.65% | 12.38% | 7.80% | 6 | 20.00% | 7 | 16.67% |
| 31 Mar, 23 | 26 | -3.70% | 8,762,397 | -8.71% | 12.60% | 6.63% | 5 | -58.33% | 6 | 100.00% |
| 31 Dec, 22 | 27 | -3.57% | 9,598,439 | -1.94% | 13.78% | 5.81% | 12 | -33.33% | 3 | - |
| 30 Sep, 22 | 28 | 47.37% | 9,788,228 | 117.69% | 15.40% | 24.00% | 18 | 157.14% | 3 | - |
| 30 Jun, 22 | 19 | -5.00% | 4,496,499 | 4.96% | 8.01% | 13.47% | 7 | -22.22% | 3 | -25.00% |
| 31 Mar, 22 | 20 | -13.04% | 4,284,086 | -3.59% | 7.71% | 11.39% | 9 | -10.00% | 4 | -42.86% |
| 31 Dec, 21 | 23 | -8.00% | 4,443,499 | 45.89% | 8.23% | 25.62% | 10 | -16.67% | 7 | 40.00% |
| 30 Sep, 21 | 25 | - | 3,045,786 | -39.29% | 5.67% | 6.46% | 12 | -25.00% | 5 | 66.67% |
| 30 Jun, 21 | 25 | -13.79% | 5,016,683 | -9.27% | 9.37% | 7.56% | 16 | -11.11% | 3 | - |
| 31 Mar, 21 | 29 | 45.00% | 5,529,053 | 139.38% | 11.13% | 50.61% | 18 | 38.46% | 3 | -40.00% |
| 31 Dec, 20 | 20 | 42.86% | 2,309,732 | 20.97% | 4.69% | 30.70% | 13 | -7.14% | 5 | - |
| 30 Sep, 20 | 14 | 1300.00% | 1,909,281 | 3377.74% | 3.91% | 30297.71% | 14 | 1300.00% | - | - |
| 30 Jun, 20 | 1 | - | 54,900 | - | 0.11% | - | 1 | - | - | - |
Medicenna Therapeutics Peer Ownership
| Ticker | Company |
|---|---|
| CKPT | Checkpoint Therapeutics, Inc. |
| CUE | Cue Biopharma, Inc. |
| MGTA | Dianthus Therapeutics, Inc. |
| ONCR | Oncorus, Inc. |
| MNPR | Monopar Therapeutics Inc. |
| ACHL | Achilles Therapeutics plc |
| IKNA | Ikena Oncology, Inc. |
| APVO | Aptevo Therapeutics Inc. |
| EWTX | Edgewise Therapeutics, Inc. |
| SABS | SAB Biotherapeutics, Inc. |
| IVVD | Invivyd, Inc. |
| SRZN | Surrozen, Inc. |
| AKTX | Akari Therapeutics, Plc |
| CNTB | Connect Biopharma Holdings Limited |
| PASG | Passage Bio, Inc. |
| VCNX | Vaccinex, Inc. |
| HOWL | Werewolf Therapeutics, Inc. |
| TARA | Protara Therapeutics, Inc. |
| PIRS | Pieris Pharmaceuticals, Inc. |
| OVID | Ovid Therapeutics Inc. |
| ELYM | Eliem Therapeutics, Inc. |
MDNA Ownership FAQ
Who Owns Medicenna Therapeutics?
Medicenna Therapeutics is owned by institutional shareholders (0.19%), insiders (23.65%), and public (76.16%). The largest institutional shareholder of Medicenna Therapeutics is WELLS FARGO & COMPANY/MN (0% of total shares) and the top mutual fund owner is FIDELITY CONCORD STREET TRUST (0.00% of total shares).
Who are the major institutional shareholders of Medicenna Therapeutics?
Medicenna Therapeutics's major institutional shareholders are WELLS FARGO & COMPANY/MN, TOCQUEVILLE ASSET MANAGEMENT L.P., MORGAN STANLEY, TORONTO DOMINION BANK, and ROYAL BANK OF CANADA. The top five shareholders own together 0% of the company's share outstanding.
How many Medicenna Therapeutics shareholders are there?
As of Dec 2023, there are 3 institutional shareholders of Medicenna Therapeutics.
What percentage of Medicenna Therapeutics is owned by WELLS FARGO & COMPANY/MN?
WELLS FARGO & COMPANY/MN owns 0 shares of Medicenna Therapeutics, representing 0% of the company's total shares outstanding, valued at $0 (as of Dec 2023).
What percentage of Medicenna Therapeutics is owned by TOCQUEVILLE ASSET MANAGEMENT L.P?
As of Dec 2023, TOCQUEVILLE ASSET MANAGEMENT L.P holds 0 shares of Medicenna Therapeutics (MDNA), compromising 0% of the company, valued at $0.
What percentage of Medicenna Therapeutics is owned by MORGAN STANLEY?
MORGAN STANLEY is the third largest holder of Medicenna Therapeutics. The company owns 0 of the company's shares outstanding (worth $0).